Stockscreener 앱 받기
4.98
5.14%
-0.27
전일 마감가:
$5.25
열려 있는:
$5.25
하루 거래량:
169.18K
Relative Volume:
0.87
시가총액:
$205.16M
수익:
-
순이익/손실:
-
주가수익비율:
-2.5172
EPS:
-1.9784
순현금흐름:
-
1주 성능:
+6.64%
1개월 성능:
+28.02%
6개월 성능:
+2.26%
1년 성능:
+0.00%
1일 변동 폭
$4.90
$5.29
1주일 범위
$4.54
$5.50
52주 변동 폭
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
AVR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
4.98 | 216.29M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Begins Global PARADIGM Trial Enrollment - MSN
Anteris Technologies Issues Restricted Stock Units - TipRanks
Anteris Technologies Announces Change in Director’s Interest - TipRanks
Anteris Technologies Issues Unquoted Securities for Employee Incentives - TipRanks
FDA Approves Anteris Technologies’ DurAVR THV Global Trial - Medical Product Outsourcing
Anteris Technologies Global : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Anteris Technologies approves key proposals at annual meeting - MSN
Anteris Technologies highlights innovations at annual meeting - MSN
Anteris Technologies reports CDI adjustments for November 2025 - MSN
Anteris Technologies Global Corp Stock Analysis and ForecastCovered Call Writing & Small Budget Investment Tips - earlytimes.in
Critical Analysis: QHSLab (OTCMKTS:USAQ) and Anteris Technologies Global (NASDAQ:AVR) - Defense World
Working capital per share of Anteris Technologies Global Corp. – ASX:AVR - TradingView
Anteris Technologies Reports CDI Adjustments for November 2025 - TipRanks
How geopolitical tensions affect Anteris Technologies Global Corp. stock2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Anteris Technologies Global shareholders approve board elections and equity grants - Investing.com Australia
Anteris Technologies Global shareholders approve board elections and equity grants By Investing.com - Investing.com South Africa
Anteris Technologies Holds Annual Stockholders Meeting - TipRanks
Why Anteris Technologies Global Corp. stock is rated strong buyJobs Report & Verified Momentum Stock Ideas - Newser
Anteris Technologies Approves Key Proposals at Annual Meeting - TipRanks
Anteris Technologies Highlights Innovations at Annual Meeting - TipRanks
Anteris Technologies Announces Cessation of Certain Securities - The Globe and Mail
Sio Capital Management LLC Decreases Stock Position in Anteris Technologies Global Corp. $AVR - MarketBeat
Anteris Technologies holds annual stockholders meeting - MSN
Anteris Technologies Announces Agreement Termination - MSN
Anteris Technologies Ends Agreement with 4C Medical - MSN
Anteris Technologies Global to end supply agreement with 4C Medical Technologies - Investing.com
Anteris Technologies ends supply deal with 4C Medical - StreetInsider
Cash per share of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Can Anteris Technologies Global Corp. stock sustain revenue growthMarket Risk Analysis & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Anteris Technologies Files Form S-1 to Enhance Market Flexibility - MSN
Anteris Technologies Reports Q3 2025 Progress and Financials - MSN
Anteris Technologies Postpones Special Stockholders Meeting - MSN
Anteris Technologies Reports Positive One-Year Outcomes for DurAVR® Heart Valve - MSN
Anteris Technologies Secures A$38.5 Million for Global Expansion - MSN
Anteris Technologies Announces Cessation of Securities - MSN
Investors in Anteris Technologies Global (ASX:AVR) have unfortunately lost 75% over the last three years - Yahoo Finance
What machine learning models say about Anteris Technologies Global Corp.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
Will Anteris Technologies Global Corp. see short term momentum2025 Institutional Moves & Weekly High Potential Alerts - newser.com
Can Anteris Technologies Global Corp. hit a new high this monthWeekly Trade Report & Real-Time Buy Zone Alerts - newser.com
Published on: 2025-11-19 06:30:50 - newser.com
Is Anteris Technologies Global Corp. stock oversold or undervalued2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Will Anteris Technologies Global Corp. continue its uptrendWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Anteris Technologies Reports Positive DurAVR® THV Outcomes - MSN
Anteris Technologies Global Corp. stock momentum explainedJuly 2025 Final Week & Risk Managed Investment Signals - newser.com
Why Anteris Technologies Global Corp. stock is seen as undervaluedDollar Strength & Growth Focused Investment Plans - newser.com
Anteris Technologies Reports Positive 30-Day Outcomes for DurAVR® THV - MSN
Promising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating - TipRanks
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves - The Manila Times
Detecting price anomalies in Anteris Technologies Global Corp. with AI2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Anteris Technologies Advances with Stockholder Approvals and PARADIGM Trial Update - MSN
Anteris unveils strong 30-day DurAVR® data in 100-patient small-annulus cohort - Proactive financial news
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anteris Technologies Global Corp 주식 (AVR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
| Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
1.32%
0.04%
자본화:
|
볼륨(24시간):